AIT Worldwide Logistics debuts new global headquarters in Chicago suburbs
Corporate teammates for supply chain solutions leader AIT Worldwide Logistics recently moved into a new global headquarters at 2 Pierce Place in Itasca, Illinois. Previously, AIT’s shared services teams were based out of multiple Itasca facilities, including 701 Rohlwing Rd., a single-story building and warehouse that had been shared with the company’s Chicago station since 1997.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230814443050/en/
AIT’s new global headquarters occupies multiple floors of the iconic 25-story suburban tower at 2 Pierce Place in Itasca, Illinois. (Photo: Business Wire)
According to AIT’s Chairman and CEO, Vaughn Moore, the move was spurred by the organization’s exponential growth and emergence as a global logistics powerhouse.
“After more than 40 years in business, and immense expansion to more than 110 locations across Asia, Europe and North America, we’re fortifying our roots in the Chicago area,” Moore said. “This modern, highly visible location is a true manifestation of our global brand, and it provides our corporate staff with both the space and resources they need to best support our customers and teammates around the world.”
Moore added that the new location is a major investment in AIT teammates’ on-site work experience.
“Working together in this state-of-the-art office space allows us to be much more collaborative, enabling faster, real-time reactions,” he said. “2 Pierce Place also provides the additional space we need to accommodate the future growth of our shared services teams.”
AIT’s global headquarters occupies multiple floors of the iconic 25-story suburban tower. Standing at 395 feet, it is the second-tallest building in Illinois outside the Chicago city limits. From its modern lobby to the tenant lounge, game room and outdoor patio, 2 Pierce Place offers popular on-site amenities, including a fitness center, walking trail, a full-service deli serving breakfast and lunch, grab-and-go dining options, and on-site catering services.
Team members from accounting, claims, finance, global business systems, global compliance, human resources, imaging, information technology, legal and marketing are stationed on newly remodeled high-rise floors with conveniences including a private game room, coffee bars, sit-stand workstations, and multiple conference rooms equipped with state-of-the-art audio-visual capabilities.
In the coming months, the remaining Chicago area AIT teams in Itasca and Wood Dale (including dedicated food logistics and life sciences locations) are planning to move into a unified multi-service facility in the nearby suburb of Palatine. This new joint office and warehouse space is under construction. Meanwhile, AIT Truckload Solutions will continue to serve customers out of their current location at 55 W. Monroe St. in Chicago.
Conveniently located near the intersection of Interstate 290 and the Elgin-O’Hare Expressway, AIT’s new global headquarters is easily accessible from O’Hare International Airport:
AIT Worldwide Logistics |
2 Pierce Place, Suite 2100 |
Itasca, IL 60143 |
Tel: +1 (630) 766-8300 |
Learn more about 2 Pierce Place at twopierceplace.com.
About AIT Worldwide Logistics
AIT Worldwide Logistics is a global freight forwarder that helps companies grow by expanding access to markets all over the world where they can sell and/or procure their raw materials, components and finished goods. For more than 40 years, the Chicago-based supply chain solutions leader has relied on a consultative approach to build a global network and trusted partnerships in nearly every industry, including aerospace, automotive, consumer retail, food, government, healthcare, high-tech, industrial and life sciences. Backed by scalable, user-friendly technology, AIT’s flexible business model customizes door-to-door deliveries via sea, air, ground and rail — on time and on budget. With expert teammates staffing more than 100 worldwide locations in Asia, Europe and North America, AIT’s full-service options also include customs clearance, warehouse management and white glove services. Learn more at www.aitworldwide.com.
Our Mission
At AIT, we vigorously seek opportunities to earn our customers’ trust by delivering exceptional worldwide logistics solutions while passionately valuing our co-workers, partners and communities.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230814443050/en/
Contact information
Matt Sanders
Public Relations Manager
+1 (630) 766-8300
msanders@aitworldwide.com
AIT Worldwide Logistics, Inc.
Corporate Headquarters
701 N. Rohlwing Road
Itasca, IL 60143
800-669-4AIT (4248)
www.aitworldwide.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Almirall Presents Long‑Term Results from First Real‑World Dermatology Study Using WHO‑5 Well‑Being Index as Primary Endpoint in the treatment of Psoriasis at EADV 202518.9.2025 09:00:00 EEST | Press release
Almirall, S.A. (ALM) a global biopharmaceutical company focused on medical dermatology today announced new long-term results from the POSITIVE study, presented as a late-breaker at the 34th Congress of the European Academy of Dermatology and Venereology 2025 (EADV) in Paris. POSITIVE is the first RWE study in dermatology to use the World Health Organization Well-Being Index (WHO-5) as a primary endpoint. The selection of the abstract as a late breaker at the EADV congress highlights the importance of the findings of the POSITIVE study and its unique approach to evaluating the long-term holistic impact of an advanced treatment in patients with moderate-to-severe psoriasis, a condition that profoundly impairs social, psychological, and physical quality of life, impacting overall well-being1. Two‑Year Real‑World Results from POSITIVE The 24-month, multinational, phase IV observational study enrolled 785 adult patients with moderate-to-severe plaque psoriasis across nine European countries
Shield and PwC UK Forge Strategic Collaboration to Deliver Future-Ready Communications Compliance18.9.2025 09:00:00 EEST | Press release
Shield, a leading AI platform for digital communication governance and archiving, today announced a collaboration with PwC UK, one of the world’s most trusted professional services firms. The alliance brings together Shield’s unified, cloud-native solution with PwC’s specialist expertise in communications surveillance delivery, regulatory compliance and complex programme execution. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250917394739/en/ Shield and PwC launch a strategic collaboration to modernize eComms surveillance with AI-driven compliance solutions for financial institutions. The collaboration is designed to support institutions as they modernise their approach to communications monitoring, helping them implement an advanced and proactive risk management approach at scale and with confidence. This joint offering provides an end-to-end solution designed to meet evolving regulatory expectations, accelerate adoption
Curatis: FDA Minutes Confirm Positive Outcome of Meeting on 9. September 2025 – Corticorelin on Track for Phase 318.9.2025 08:00:00 EEST | Press release
Curatis Holding AG (SIX:CURN) received the official minutes from the FDA meeting which took place on 9. September. Based on the totality of the feedback and discussions, Curatis can proceed as planned with the clinical development of corticorelin. Corticorelin is under development as a novel treatment intended to reduce or even eliminate steroid use and associated toxicities thereby potentially impacting the quality of life of patients suffering from peritumoral brain edema (PTBE) associated with metastatic (secondary) brain tumors. The virtual meeting with the FDA provided the opportunity to discuss the clinical development plan for corticorelin and encompassed CMC (Chemistry, Manufacturing and Control), nonclinical and clinical aspects. The offical FDA minutes which Curatis received after publication of the half year results reflect the positive outcome. Curatis may proceed without delay to a regulatory submission supporting a pivotal study in patients suffering from PTBE secondary t
Merck Opens Climate-Neutral €150 Million Filter Manufacturing Facility in Ireland18.9.2025 08:00:00 EEST | Press release
Merck, a leading science and technology company, has opened today its €150 million filter manufacturing facility in Blarney Business Park, Cork, Ireland. The site is Merck’s first manufacturing facility designed for full climate-neutral operations, marking a key milestone in the company’s ambition to achieve climate neutrality by 2040. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250917767425/en/ Merck's new Blarney site in Cork expands company's filter capacity, creating 200+ jobs by 2028 The 3,000-square-meter cleanroom facility supports global demand for critical filtration products used in the manufacturing of vaccines and life-saving therapies, including monoclonal antibodies, and emerging modalities like cell and gene therapies. By localizing these capacities in Europe, Merck hopes to reduce cross-border dependencies for the company’s customers. “Ireland is a leading hub for biopharmaceutical manufacturing and innova
Galderma Launches Transformative Skincare Segment With Cetaphil’s New Skin Activator Hydrating & Firming Line, in Partnership With Actor and Filmmaker Mariska Hargitay18.9.2025 08:00:00 EEST | Press release
Galderma today announced Cetaphil, the dermatologist-recommended brand trusted by millions with sensitive skin, is redefining daily skincare with its new Skin Activator Hydrating & Firming line. The launch marks an entirely new skincare segment of advanced hydration and firming solutions designed specifically for improving the appearance of aging, thinning, and fragile skin. As people age, surface skin cells stop performing at the same level, or “go to sleep,” causing fine lines, dehydration, and looser skin, in turn leading to skin looking and feeling less firm and more fragile.1 Skin Activator technology serves as a “wake-up call” to sleeping surface skin cells. The unique complex is powered by encapsulated CICA to help restore the skin’s moisture barrier to visibly plump and firm skin as well as microdosed mandelic acid to increase surface skin cell turnover to visibly reduce dull, uneven skin. In clinical trials, the Skin Activator Hydrating & Firming Lotion showed to be effective
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom